Back
Collegium Pharmaceutical 10K Form
Sell
19
COLL
Collegium Pharmaceutical
Last Price:
$28.11
Seasonality Move:
-5.05%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-07 | 10Q | COLL/Collegium Pharmaceutical Quarterly |
2023-08-03 | 10Q | COLL/Collegium Pharmaceutical Quarterly |
2023-05-04 | 10Q | COLL/Collegium Pharmaceutical Quarterly |
2022-11-03 | 10Q | COLL/Collegium Pharmaceutical Quarterly |
2022-08-04 | 10Q | COLL/Collegium Pharmaceutical Quarterly |
2022-05-10 | 10Q | COLL/Collegium Pharmaceutical Quarterly |
Receive COLL News And Ratings
See the #1 stock for the next 7 days that we like better than COLL
COLL Financial Statistics
Sales & Book Value
Annual Sales: | $631.4M |
---|---|
Cash Flow: | $84.1M |
Price / Cash Flow: | 5.62 |
Annual Sales: | $7.28 |
Price / Book: | 3.87 |
Profitability
EPS (TTM): | 1.86000 |
---|---|
Net Income (TTM): | $69.2M |
Gross Margin: | $377.3M |
Return on Equity: | 31.53% |
Return on Assets: | 5.23% |
Collegium Pharmaceutical Earnings Forecast
Key Collegium Pharmaceutical Financial Ratios
-
The Gross Profit Margin over the past 11 years for COLL is 59.76%.
-
The Selling, General & Administrative Expenses for COLL have been equal to 33.31% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 106.91% of Operating Income.
-
The Net Earning history of COLL is 10.96% of Total Revenues.
-
Per Share Earnings over the last 12 years have been positive in 8 years.
Collegium Pharmaceutical Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | COLL |
CUSIP: | 19459J |
Website: | collegiumpharma.com |
Debt
Debt-to-Equity Ratio: | 3.73 |
---|---|
Current Ratio: | 0.95 |
Quick Ratio: | 0.77 |
Price-to-Earnings
Trailing P/E Ratio: | 15.13 |
---|---|
Forward P/E Ratio: | 3.86 |
COLL Technical Analysis vs Fundamental Analysis
Sell
19
Collegium Pharmaceutical (COLL)
is a Sell
Is Collegium Pharmaceutical a Buy or a Sell?
-
Collegium Pharmaceutical stock is rated a SellThe current Collegium Pharmaceutical [COLL] share price is $28.14. The Score for COLL is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.